MEDICINES CO's ticker is MDCO and the CUSIP is 584688105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $48,151,000 | +75.8% | 566,881 | +3.5% | 0.01% | +62.5% |
| Q3 2019 | $27,382,000 | +30.7% | 547,653 | -4.7% | 0.01% | +33.3% |
| Q2 2019 | $20,958,000 | +74.7% | 574,680 | +33.9% | 0.01% | +50.0% |
| Q1 2019 | $11,998,000 | +59.4% | 429,282 | +9.1% | 0.00% | +33.3% |
| Q4 2018 | $7,529,000 | -29.5% | 393,389 | +10.1% | 0.00% | 0.0% |
| Q3 2018 | $10,687,000 | -18.5% | 357,301 | 0.0% | 0.00% | -40.0% |
| Q2 2018 | $13,113,000 | +11.4% | 357,301 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $11,770,000 | -16.5% | 357,301 | -30.7% | 0.00% | -20.0% |
| Q4 2017 | $14,093,000 | -26.2% | 515,477 | 0.0% | 0.01% | -28.6% |
| Q3 2017 | $19,093,000 | +5.0% | 515,477 | +7.8% | 0.01% | 0.0% |
| Q2 2017 | $18,178,000 | -22.3% | 478,250 | 0.0% | 0.01% | -30.0% |
| Q1 2017 | $23,386,000 | +3.5% | 478,250 | -28.2% | 0.01% | 0.0% |
| Q4 2016 | $22,599,000 | -5.8% | 665,846 | 0.0% | 0.01% | -9.1% |
| Q3 2016 | $24,001,000 | +24.6% | 665,846 | +16.3% | 0.01% | +22.2% |
| Q2 2016 | $19,261,000 | +5.9% | 572,744 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $18,196,000 | -14.9% | 572,744 | 0.0% | 0.01% | -18.2% |
| Q4 2015 | $21,386,000 | +63.7% | 572,744 | +66.4% | 0.01% | +57.1% |
| Q3 2015 | $13,065,000 | +22.6% | 344,184 | -7.6% | 0.01% | +40.0% |
| Q2 2015 | $10,660,000 | -22.1% | 372,582 | -23.7% | 0.01% | -28.6% |
| Q1 2015 | $13,685,000 | -8.1% | 488,410 | -9.2% | 0.01% | -12.5% |
| Q4 2014 | $14,888,000 | +62.9% | 538,053 | +31.4% | 0.01% | +60.0% |
| Q3 2014 | $9,141,000 | -61.6% | 409,518 | -50.0% | 0.01% | -16.7% |
| Q2 2014 | $23,800,000 | +117.2% | 819,036 | +112.4% | 0.01% | 0.0% |
| Q1 2014 | $10,958,000 | -27.8% | 385,585 | -1.9% | 0.01% | -33.3% |
| Q4 2013 | $15,184,000 | +15.2% | 393,150 | 0.0% | 0.01% | +12.5% |
| Q3 2013 | $13,178,000 | +85.7% | 393,150 | +70.5% | 0.01% | +100.0% |
| Q2 2013 | $7,095,000 | -8.0% | 230,648 | 0.0% | 0.00% | -20.0% |
| Q1 2013 | $7,708,000 | +74.5% | 230,648 | +34.7% | 0.01% | +66.7% |
| Q3 2012 | $4,418,000 | +3.1% | 171,188 | 0.0% | 0.00% | 0.0% |
| Q2 2012 | $4,286,000 | – | 171,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |